> Home

 > How to reach us

 > Site map

 



 


Organizational Structure

The PNG Gerolymatos is comprised of several distinct business units and conducts business through numerous legal entities. The philosophy of decentralized management, which fosters an entrepreneurial spirit, is deeply entrenched in the Company's culture and is viewed by management as essential to the success of its broadly based businesses.

Organized on the principles of decentralized management, each division is headed by a Managing Director who has overall responsibility for the business unit. Support functions such as Finance, Information Technology and Human Resources are leveraged across all divisions under a Shared Services arrangement.

The Company’s Board of Directors provides the oversight of management and is the ultimate decision-making body of the Company except with respect to matters requiring shareholder approvals. Board Members are elected by the Company’s shareholders. The Board has 9 members, 2 of which are independent. The Board of Directors has two standing committees:

  • The Audit Committee is comprised of non-employee Directors. This Committee helps oversee the Company's accounting and reporting practices, monitors the adequacy of internal control systems and reviews accounting policies.
     

  • The Strategic Planning Committee is comprised of employee Directors and is responsible for setting overall strategic direction.

Under the chairmanship of the Chief Executive Officer, the Executive Committee is the principal management body of the Company. The Executive Committee is comprised of senior line executives and is responsible for implementing strategy, overseeing and coordinating activities, and aligning management to meet the needs of the markets where the Company competes.
The Chief Executive Officer is responsible for providing leadership and integrating the various activities and functions of the Company. As the Company’s top executive, the CEO is responsible for the overall performance of the Company. All executive directors report to the Chief Executive Officer.

The Chief Operating Officer provides the management oversight for the Company’s operations in Greece. In this capacity, the Managing Directors that head each business unit in Greece report to the Chief Operating Officer. In addition to these responsibilities, the COO also has responsibility for Information Technology.

The Vice President, Corporate Business Development directs the Company's Business Development initiatives. This entails identifying and developing in-licensing collaborative programs and implementing out-licensing strategies. In addition to these responsibilities, he also oversees the Company's export activities and international subsidiaries, and has responsibility for Research & Development activities.

BOARD OF DIRECTORS

EXECUTIVE TEAM

Mr. Panagiotis Gerolymatos
Chairman of the Board

Mr. Nicholas Gerolymatos
Vice Chairman of the Board

Mr. Norbert Schmidt-Gollas
Chief Executive Officer

Mr. George Joakimidis
Executive Member

Mr. Alexandros Kirlibas
Executive Member

Mr. Periklis Livas
Non Executive Member

Mr. Aristotelis Charalampakis
Non Executive Member

Mr. Nikolaos Karantanis
Non Executive Member

Ms Maria Mpirmpili
Non Executive Member
 


Mr. Norbert Schmidt-Gollas
Chief Executive Officer

Mr. Alberto Manouach
Vice President, Corporate Business Development

Mr. George Joakimidis
Vice President, Chief Operating Officer

Mr. Alexandros Kirlibas
Vice President, Chief Financial Officer

Mr. Simeon Kefalas
Vice President, Manufacturing & Technical Services

Mr. Theodoros Papafotopoulos
Vice President, Human Resources Director

Mr. George Panagiotopoulos
Vice President, Corporate & Legal Affairs


Group Organizational Chart



 

BUSINESS UNIT MANAGING DIRECTORS - GREECE

Pharmaceuticals: Mr. Nikos Stathopoulos

Cosmetics & Consumer: Mr. Larry Sakellariou

Diagnostics: Mr. Andreas Papavasiliou

Animal Health: Mrs. Fotini Stamatelatou

OTC: Mr. Serafeim Tourlidas

Services: Mr. Tassos Pantazis



SUBSIDIARY PRESIDENTS & MANAGING DIRECTORS – GREECE

Gerolpharm S.A.: Mr. Nikos Kokotsakis (President) & Mrs Katerina Nikolaou (Managing Director)

Santa Pharma S.A.: Mr. Nikolaos Manassakis (President) – Mr. Dimitris Papanayotou (Managing Director)

PNG Gerolymatos Medical S.A.: Mr. Dimitris Sakkas (President & Managing Director)

Health Logistics S.A.: Mr. Nicholas Gerolymatos (President) – Mr. Tassos Pantazis (Managing Director)



SUBSIDIARY PRESIDENTS & MANAGING DIRECTORS – INTERNATIONAL

Gerolymatos Inc.: Mr. Panagiotis Gerolymatos (President) – Mr. Alberto Manouach (Executive VP)

Genesis Labs Ltd: Mr. Panagiotis Gerolymatos (Administrator) - Mr. Pavlos Kontomihalos (Administrator)

Palcrest Limited: Mr. Alexandros Kirlibas (Administrator) – Mr. Dimitris Sklavounos (Administrator)

Laboratoires A.I.M.: Mrs. Marie-Claire Diouron (President) – Mr. Marcel Diouron (Managing Director)

Foltene Laboratories S.P.A.: Mr. Gian Pietro Leoni (President) – Mrs. Ornella Introzzi (Managing Director)

Genesis Ilaç: Mr. Panagiotis Gerolymatos (President) – Mr. Cemal Boke (Managing Director)

Natural Pharma S.A.: Mr. Gian Pietro Leoni (President)

Larus Pharma S.R.L.: Mr. Gian Pietro Leoni (President) – Mr. Roberto Modanesi (Managing Director)

 

Copyright © Gerolymatos Group of Companies